Kishor M Wasan Selected Research

Peceol

1/2007

Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kishor M Wasan Research Topics

Disease

14	Neoplasms (Cancer) 09/2021 - 01/2002
9	Prostatic Neoplasms (Prostate Cancer) 09/2021 - 11/2007
6	Hypercholesterolemia 04/2019 - 12/2002
6	Atherosclerosis 12/2012 - 01/2003
6	Dyslipidemias (Dyslipidemia) 07/2009 - 12/2002
5	Mycoses (Diseases, Fungus) 01/2020 - 01/2002
4	Visceral Leishmaniasis (Kala Azar) 12/2010 - 03/2009
4	Body Weight (Weight, Body) 08/2005 - 01/2003
3	Acquired Immunodeficiency Syndrome (AIDS) 01/2020 - 01/2002
3	Inborn Genetic Diseases (Disease, Hereditary) 06/2017 - 09/2010
3	Disease Progression 01/2014 - 03/2010
3	Hyperlipidemias (Hyperlipidemia) 07/2009 - 08/2002
3	Infections 05/2009 - 01/2003
3	Sepsis (Septicemia) 08/2008 - 01/2004
2	Osteoporosis 06/2021 - 05/2013
2	Melanoma (Melanoma, Malignant) 01/2019 - 07/2002
2	Leukemia 01/2019 - 03/2007
2	Neoplasm Metastasis (Metastasis) 01/2019 - 10/2002
2	Aniridia 06/2017 - 01/2014
2	Systemic candidiasis 01/2015 - 10/2013
2	Invasive Fungal Infections 01/2015 - 03/2009
2	Obesity 06/2011 - 08/2005
2	Hypertriglyceridemia 08/2010 - 06/2008
2	Septic Shock (Toxic Shock Syndrome) 08/2008 - 01/2008
2	Weight Gain 09/2007 - 08/2005
2	Rheumatoid Arthritis 03/2007 - 04/2004
2	Insulin Resistance 01/2006 - 02/2003
2	Weight Loss (Weight Reduction) 08/2005 - 01/2003
2	Inflammation (Inflammations) 09/2004 - 04/2004
2	Endotoxemia 09/2004 - 01/2004
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 01/2022
1	Whooping Cough (Pertussis) 01/2022
1	Communicable Diseases (Infectious Diseases) 10/2019
1	Parasitic Diseases (Parasitic Disease) 02/2019
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019
1	Lung Diseases (Lung Disease) 11/2017
1	Wounds and Injuries (Trauma) 11/2017
1	Eye Infections 11/2017
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 11/2017
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2015
1	Liver Diseases (Liver Disease) 01/2015
1	Neglected Diseases 11/2014
1	Rare Diseases (Rare Disease) 11/2014

Drug/Important Bio-Agent (IBA)

14	LipidsIBA 01/2022 - 07/2002
14	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2020 - 01/2002
13	Pharmaceutical PreparationsIBA 01/2020 - 01/2002
12	CholesterolIBA 09/2021 - 01/2002
7	AndrogensIBA 09/2021 - 01/2008
6	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2002
6	Lipoproteins (Lipoprotein)IBA 07/2009 - 01/2002
4	Scavenger Receptors (Scavenger Receptor)IBA 09/2021 - 06/2012
4	EnzymesIBA 03/2014 - 01/2003
4	Blood Proteins (Serum Proteins)IBA 07/2009 - 07/2002
3	SteroidsIBA 09/2021 - 02/2010
3	Lanthanoid Series Elements (Lanthanides)IBA 06/2021 - 11/2007
3	Androgen Receptors (Androgen Receptor)IBA 01/2019 - 02/2010
3	HDL CholesterolIBA 01/2019 - 09/2004
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2014 - 07/2009
2	Phytosterols (Plant Sterols)IBA 04/2019 - 06/2011
2	Nonsense Codon (Nonsense Mutation)IBA 06/2017 - 01/2014
2	Biological ProductsIBA 01/2012 - 09/2007
2	Clozapine (Clozaril)FDA LinkGeneric 08/2010 - 09/2007
2	liposomal amphotericin B FDA Link 03/2010 - 06/2004
2	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 03/2010 - 07/2006
2	Fatty Acids (Saturated Fatty Acids)IBA 02/2010 - 09/2004
2	halofantrine (Halfan)FDA Link 07/2009 - 08/2002
2	Toll-Like Receptor 4IBA 08/2008 - 01/2008
2	eritoranIBA 01/2008 - 09/2004
2	E5564IBA 01/2008 - 01/2004
2	HomocysteineIBA 01/2006 - 01/2004
2	Haloperidol (Haldol)FDA LinkGeneric 10/2005 - 01/2003
1	Vaccine AdjuvantsIBA 01/2022
1	Anti-Infective Agents (Microbicides)IBA 01/2022
1	Pertussis VaccineIBA 01/2022
1	VaccinesIBA 01/2022
1	LanthanumIBA 06/2021
1	Tocopherols (Tocopherol)IBA 04/2019
1	AntioxidantsIBA 04/2019
1	CPX-351IBA 01/2019
1	AntigensIBA 01/2019
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2019
1	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2019
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	Liposomes (Liposome)IBA 01/2019
1	Surface-Active Agents (Surfactants)IBA 01/2019
1	Lipoprotein Receptors (Lipoprotein Receptor)IBA 01/2019
1	PolymersIBA 11/2017
1	ChitosanIBA 11/2017
1	Diazepam (Valium)FDA LinkGeneric 01/2015
1	BenzodiazepinesIBA 01/2015
1	Lorazepam (Ativan)FDA LinkGeneric 01/2015

Therapy/Procedure

10	Therapeutics 09/2021 - 07/2009
7	Castration 09/2021 - 02/2010
3	Oral Administration 08/2010 - 03/2009
2	Organ Transplantation 01/2020 - 03/2007
2	Drug Therapy (Chemotherapy) 10/2019 - 01/2018
1	Image-Guided Radiotherapy 01/2019
1	Precision Medicine 01/2018
1	Radiotherapy 01/2018
1	Phototherapy (Light Therapy) 01/2018